Research map: Targeting Epstein-Barr Virus for Cancer Vaccines: Recent Advances and Future Directions

Back to the article

Papers in this map

  1. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV · Cong Sun · 2023 · 77 citations · Cited by this paper
  2. In vivo intratumoral heterogeneity in a dish: scalable forebrain organoid models of embryonal brain tumors for high‐throughput personalized drug discovery · 2025 · Related
  3. The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up · Yongfeng Si · 2016 · 51 citations · Cited by this paper
  4. Anbenitamab in combination with chemotherapy in patients with HER2‐positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC‐WISE 01) · 2025 · Related
  5. A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma · Mengran Guo · 2023 · 42 citations · Cited by this paper
  6. A practical overview and statistical analysis of interval‐censored data in cancer · 2025 · Related
  7. mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice · Ge‐Xin Zhao · 2023 · 38 citations · Cited by this paper
  8. The Roles of Protein S -Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential · 2026 · Related
  9. Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit · Emily Pauline Nickles · 2021 · 29 citations · Cited by this paper
  10. WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular Carcinoma · 2026 · Related
  11. EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity · Nannan Zhu · 2021 · 28 citations · Cited by this paper
  12. Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma · 2026 · Related
  13. Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization · Cong Sun · 2025 · 16 citations · Cited by this paper
  14. CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer · 2025 · Related
  15. A broadly protective antibody targeting gammaherpesvirus gB · Cong Sun · 2026 · 11 citations · Cited by this paper
  16. Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial · 2025 · Related
  17. Safety, tolerability, and immunogenicity of WGc-043 in subjects with EBV-positive cancers: Results from an investigator-initiated trial. · Xingchen Peng · 2024 · 9 citations · Cited by this paper
  18. HMGB3 promotes brain metastasis of lung adenocarcinoma by recruiting SSBP1 for nuclear translocation to remodel mitochondrial metabolism · 2025 · Related
  19. 811MO An exploratory study to assess the safety, immunogenicity, and preliminary anti-tumor activity of the EBV mRNA vaccine (WGc-043 injection) in patients with NK/T cell lymphoma · Xueqiang Peng · 2024 · 1 citation · Cited by this paper
  20. Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study · 2026 · Related

Source: OpenAlex (CC0)